In order to identify potential biomarkers for AFP negative HCC, the top 7 ranked differential metabolites in the respective models were selected according to the mean decrease accuracy (MDA), which denoted the percent decrease in accuracy when the trial was performed in the absence of the metabolite (Figure 3A). Here, AFP is linked to hepatocellular carcinoma.